Al-mahallawi AM, Abdelbary AA, Aburahma MH (2015) Investigating the potential of employing

bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam. Int J Pharm 485(1):

329–340

Alshweiat A, Katona G, Csóka I, Ambrus R (2018) Design and characterization of loratadine

nanosuspension prepared by ultrasonic-assisted precipitation. Eur J Pharm Sci 122:94–104

Alshweiat A, Ambrus R, Katona G, Csoka I (2019) QbD based control strategy of loratadine

nanosuspensions and dry nanoparticles stabilized by Soluplus. Farmacia 67:729–735

Araujo PW, Brereton RG (1996) Experimental design III. Quantification. Trends Anal Chem 15

(3):156–163

Armstrong NA, James KC (1991) Understanding experimental design and interpretation in

pharmaceutics. Elsevier, Netherlands

Arora S, Rajwade JM, Paknikar KM (2012) Nanotoxicology and in vitro studies: the need of the

hour. Toxicol Appl Pharmacol 258(2):151–165

Asfaram A, Ghaedi M, Purkait K (2017) Novel synthesis of nanocomposite for the extraction of

sildenafil citrate (Viagra) from water and urine samples: process screening and optimization.

Ultrason Sonochem 38:463–472

Attari Z, Kalvakuntla S, Reddy MS, Deshpande M, Rao CM, Koteshwara KB (2016) Formulation

and characterisation of nanosuspensions of BCS class II and IV drugs by combinative method. J

Exp Nanosci 11(4):276–288

Avasatthi V, Pawar H, Dora CP, Bansod P, Gill MS, Suresh S (2016) A novel nanogel formulation

of methotrexate for topical treatment of psoriasis: optimization, in vitro and in vivo evaluation.

Pharm Dev Technol 21(5):554–562

Aziz DE, Abdelbary AA, Elassasy AI (2018) Fabrication of novel elastosomes for boosting the

transdermal delivery of diacerein: statistical optimization, ex-vivo permeation, in-vivo skin

deposition and pharmacokinetic assessment compared to oral formulation. Drug Deliv 25(1):

815–826

Bandyopadhyay S, Beg S, Katare OP, Sharma G, Singh B (2015) QbD-oriented development of

self-nanoemulsifying drug delivery systems (SNEDDS) of valsartan with improved biopharma-

ceutical performance. Curr Drug Deliv 12(5):544–563

Baughman RH, Zakhidov AA, De Heer WA (2002) Carbon nanotubes—the route toward

applications. Science 297(5582):787–792

Beg S, Swain S, Singh HP, Patra C, Rao MEB (2012) Development, optimization, and characteri-

zation of solid self-nanoemulsifying drug delivery systems of valsartan using porous carriers.

AAPS PharmSciTech 13(4):1416–1427

Beg S, Sandhu PS, Batra RS, Khurana RK, Singh B (2015a) QbD-based systematic development of

novel optimized solid self-nanoemulsifying drug delivery systems (SNEDDS) of lovastatin with

enhanced biopharmaceutical performance. Drug Deliv 22(6):765–784

Beg S, Sharma G, Thanki K, Jain S, Katare OP, Singh B (2015b) Positively charged self-

nanoemulsifying oily formulations of olmesartan medoxomil: systematic development,

in vitro, ex vivo and in vivo evaluation. Int J Pharm 493(1):466–482

Beg S, Jain S, Kushwah V, Bhatti GK, Sandhu PS, Katare OP, Singh B (2017a) Novel surface-

engineered solid lipid nanoparticles of rosuvastatin calcium for low-density lipoprotein-receptor

targeting: a quality by design-driven perspective. Nanomedicine 12(4):333–356

Beg S, Katare OP, Singh B (2017b) Formulation by design approach for development of ultrafine

self-nanoemulsifying systems of rosuvastatin calcium containing long-chain lipophiles for

hyperlipidemia management. Colloids Surf B Biointerfaces 159:869–879

Beg S, Saini S, Bandopadhyay S, Katare OP, Singh B (2018) QbD-driven development and

evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multi-

variate statistical techniques. Drug Dev Ind Pharm 44(3):407–420

Beg S, Rahman M, Kohli K (2019) Quality-by-design approach as a systematic tool for the

development of nanopharmaceutical products. Drug Discov Today 24(3):717–725

Bera D, Qian L, Tseng T-K, Holloway PH (2010) Quantum dots and their multimodal applications:

a review. Materials 3(4):2260–2345

18

QbD-Steered Systematic Development of Drug Delivery Nanoconstructs:. . .

343